NCT03488446|Unknown
Loading search results
Sponsor study identifier
observational
500
1 country
1
Study Start
August 30, 2017
Actual (reported)Primary Completion
August 31, 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
March 31, 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
This study proposes to establish a CT radiomics-based prediction model for identifying metastasis of each station lymph nodes in gastric cancer.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 31, 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 30, 2017
Actual (reported)September 30, 2017
Actual (reported)April 5, 2018
Actual (reported)August 31, 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
March 31, 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Pathological lymph node status of every station
Pathological lymph node status of each station is defined as lymph node metastasis exist or not
Pathologic evaluation will be performed for each patient within 1 week after surgery
Survival time
Follow-up from the date of surgery to the date of death.
Lymph node stage (N stage)
Pathologic evaluation will be performed for each patient within 1 week after surgery
pathologically proven gastric cancer patients who receive preoperative CT and surgical resection in these hospitals.
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, 510-515, China
Gillies RJ, Kinahan PE, Hricak H. Radiomics: Images Are More than Pictures, They Are Data. Radiology. 2016 Feb;278(2):563-77. doi: 10.1148/radiol.2015151169. Epub 2015 Nov 18.
Aerts HJ, Velazquez ER, Leijenaar RT, Parmar C, Grossmann P, Carvalho S, Bussink J, Monshouwer R, Haibe-Kains B, Rietveld D, Hoebers F, Rietbergen MM, Leemans CR, Dekker A, Quackenbush J, Gillies RJ, Lambin P. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014 Jun 3;5:4006. doi: 10.1038/ncomms5006.
Guoxin Li, M.D., PH.D.
Nanfang Hospital, Southern Medical University
First Submitted
September 30, 2017
First Posted
April 5, 2018
Study Start
August 30, 2017
Actual (reported)Primary Completion
August 31, 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study
Contact the study team to confirm eligibility.
Huang YQ, Liang CH, He L, Tian J, Liang CS, Chen X, Ma ZL, Liu ZY. Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer. J Clin Oncol. 2016 Jun 20;34(18):2157-64. doi: 10.1200/JCO.2015.65.9128. Epub 2016 May 2.
Study Completion
March 31, 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
April 5, 2018
Record last verified: 2017-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: